Canfield et al., 1995 - Google Patents
Evidence that tenascin and thrombospondin-1 modulate sprouting of endothelial cellsCanfield et al., 1995
- Document ID
- 477501135573062155
- Author
- Canfield A
- Schor A
- Publication year
- Publication venue
- Journal of cell science
External Links
Snippet
Cultured endothelial cells undergo a reversible transition from a resting (cobblestone) phenotype to an angiogenic (sprouting) phenotype. This transition mimics the early events of angiogenesis. We have previously reported that the addition of exogenous xylosides inhibits …
- 102000007000 Tenascin 0 title abstract description 89
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Canfield et al. | Evidence that tenascin and thrombospondin-1 modulate sprouting of endothelial cells | |
Green et al. | Distribution of hyaluronate and hyaluronate receptors in the adult lung | |
Dowthwaite et al. | An essential role for the interaction between hyaluronan and hyaluronan binding proteins during joint development | |
Irwin et al. | Inter-and intra-site heterogeneity in the expression of fetal-like phenotypic characteristics by gingival fibroblasts: potential significance for wound healing | |
Jones et al. | Tenascin-C inhibits extracellular matrix-dependent gene expression in mammary epithelial cells: localization of active regions using recombinant tenascin fragments | |
Birk et al. | Collagen fibrillogenesis in vitro: interaction of types I and V collagen regulates fibril diameter | |
Stahl et al. | The role of laminin-5 and its receptors in mammary epithelial cell branching morphogenesis | |
Thesleff et al. | Changes in the distribution of tenascin during tooth development | |
Arciniegas et al. | Transforming growth factor beta 1 promotes the differentiation of endothelial cells into smooth muscle-like cells in vitro | |
Whitby et al. | Rapid epithelialisation of fetal wounds is associated with the early deposition of tenascin | |
Xu et al. | Rescue of the mutant phenotype by reexpression of full-length vinculin in null F9 cells; effects on cell locomotion by domain deleted vinculin | |
Kabosova et al. | Compositional differences between infant and adult human corneal basement membranes | |
Herold‐Mende et al. | Clinical impact and functional aspects of tenascin‐C expression during glioma progression | |
Latif et al. | Modulation of human valve interstitial cell phenotype and function using a fibroblast growth factor 2 formulation | |
Hoffman et al. | Role of laminin-1 and TGF-β3 in acinar differentiation of a human submandibular gland cell line (HSG) | |
Clark et al. | TGF‐β1 stimulates cultured human fibroblasts to proliferate and produce tissue‐like fibroplasia: A fibronectin matrix‐dependent event | |
Richardson et al. | Regulation of heparan sulfate proteoglycan nuclear localization by fibronectin | |
Chammas et al. | Laminin and tenascin assembly and expression regulate HC11 mouse mammary cell differentiation | |
Sutton et al. | The response of endothelial cells to TGF β-1 is dependent upon cell shape, proliferative state and the nature of the substratum | |
Aplin et al. | The extracellular matrix of human amniotic epithelium: ultrastructure, composition and deposition | |
Citi et al. | Cytoskeletal involvement in the modulation of cell-cell junctions by the protein kinase inhibitor H-7 | |
Canfield et al. | Association of thrombospondin-1 with osteogenic differentiation of retinal pericytes in vitro | |
Hayashi et al. | Secretion of collagen types I and II by epithelial and endothelial cells in the developing chick cornea demonstrated by in situ hybridization and immunohistochemistry | |
Schor et al. | Fibroblasts from cancer patients display a mixture of both foetal and adult-like phenotypic characteristics | |
Schenk et al. | The fibrinogen globe of tenascin-C promotes basic fibroblast growth factor-induced endothelial cell elongation |